Antineoplastic Therapy and Immunotherapy 2022 Winter Course

February 10, 2022 to March 18, 2022

This four-day course is designed to address the needs of the nursing and other oncology professionals in relation to chemotherapy and biological therapies.  It includes information on current and investigational pharmacotherapy, safe handling, administration of antineoplastic agents, and various issues concerning the management of patients receiving cancer therapy.

Target Audience

Any provider who will care for patients' receiving antineoplastic therapy and immunotherapy. 

Learning Objectives

Learning Objectives
After participation in this activity, the learner will be able to:
• Discuss the expectations related to class content and the participant’s professional responsibilities
• Discuss the roles of chemotherapy and biotherapy in the treatment of cancer
• Recall the pharmacology of different classes of antineoplastic and supportive therapies
• Recognize side effects and organ toxicities that patients may experience while receiving antineoplastic and supportive therapies
• Discuss management strategies for patients receiving antineoplastic and/or supportive therapies, including the prevention and         treatment of toxicities and side effects
• Describe the safe administration of antineoplastic and supportive therapies
• Identify interventions to prevent chemotherapy errors
• Develop a patient care management plan for a patient receiving antineoplastic therapies and supportive therapies
• Identify three resources for oncology healthcare providers to utilize

Course summary
Available credit: 
  • 25.25 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 25.25 APA
  • 25.25 Attendance
Course opens: 
12/22/2021
Course expires: 
04/15/2023
Event starts: 
02/10/2022 - 8:00am EST
Event ends: 
03/18/2022 - 5:00pm EDT
Rating: 
0

Comprehensive Chemotherapy and Biological Therapies Course
This four-day course is designed to address the needs of the nursing and other oncology professionals in relation to chemotherapy and biological therapies. It includes information on current and investigational pharmacotherapy, safe handling, administration of antineoplastic agents, and various issues concerning the management of patients receiving cancer therapy.
This course is NOT a certification course and is not intended to measure competency. Individual institutions are responsible for determining their own requirements for assessing clinical competency.

UPMC Hillman Cancer Center
Pittsburgh, PA 15232
United States

Live class to be held at UPMC Shadyside campus at the following locations:

Day One: Thursday, February 10, 202, Herberman 201 AB

Day Two: Monday, February 14, 2022, West Wing Auditorium

Day Three: Wednesday, February 23, 2022, Cooper BC

Day Four: Friday, March 4, 2022 Herberman 201 AB
 

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria.

This activity is designated for 25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

The maximum number of hours awarded for this Continuing Nursing Education activity is 25 contact hours.

To receive 25.25 Contact Hours, the learner must sign in, attend the entire activity, pass course test with a score of 80% or greater and complete the activity evaluation.

Available Credit

  • 25.25 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 25.25 APA
  • 25.25 Attendance
Please login or register to take this course.